To make a new vector conditionally replicable in tumor cells, a telomerase reverse transcriptase promoter (TERTp) is used to control the reinstated viral replication E1A gene by exploiting the elevated telomerase activity in tumor cells but that is absent in normal post mitotic cells.10 This evidence concerns the gene DHTKD1 and neoplasm.